Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation

New England Journal of Medicine

Volumn 370, Issue 5, 2014, Pages 421-432

  Cunha, Cristina ^a   Aversa, Franco ^b   Lacerda, João F ⁱ   Busca, Alessandro ^c   Kurzai, Oliver ^m   Grube, Matthias ⁿ   Löffler, Jürgen ^o   Maertens, Johan A ^p   Bell, Alain S ^a   Inforzato, Antonio ^d   Barbati, Elisa ^d   Almeida, Bruno ^j   Santos E Sousa, Pedro ⁱ   Barbui, Anna ^c   Potenza, Leonardo ^f   Caira, Morena ^g   Rodrigues, Fernando ^k,l   Salvatori, Giovanni ^h   Pagano, Livio ^g   Luppi, Mario ^f   Mantovani, Alberto ^d,e   Velardi, Andrea ^a   Romani, Luigina ^a   Carvalho, Agostinho ^a,k,l   more..

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h Sigma Tau SpA   (Italy)

ⁱ UNIVERSITY OF LISBON   (Portugal)

^j UNIVERSITY OF PORTO   (Portugal)

^k UNIVERSITY OF MINHO   (Portugal)

^l UNIVERSITY OF MINHO   (Portugal)

^m FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁿ UNIVERSITY OF REGENSBURG   (Germany)

^o UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PENTRAXIN 3;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SCREENING; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFECTION RISK; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PTX3 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84893065011     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1211161     Document Type: Article

References (30)

1. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005;23:337-66. (Pubitemid 40563173)
2. Souza DG, Soares AC, Pinho V, et al. Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol 2002;160:1755-65. (Pubitemid 34525655)
3. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002;420:182-6. (Pubitemid 35340122)
4. Moalli F, Doni A, Deban L, et al. Role of complement and Fcgamma receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010;116:5170-80.
5. Tierney L, Linde J, Müller S, et al. An interspecies regulatory network inferred from simultaneous RNA-seq of Candida albicans invading innate immune cells. Front Microbiol 2012;3:85.
6. Diniz SN, Nomizo R, Cisalpino PS, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 2004;75:649-56. (Pubitemid 38405656)
7. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007;204:793-804. (Pubitemid 46631609)
8. D'Angelo C, De Luca A, Zelante T, et al. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J Immunol 2009;183:4609-18.
9. Gaziano R, Bozza S, Bellocchio S, et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 2004;48:4414-21. (Pubitemid 39434905)
10. Lo Giudice P, Campo S, De Santis R, Salvatori G. Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2012;56:6400-2.
11. Salvatori G, Campo S. Current understanding of PTX3 protective activity on Aspergillus fumigatus infection. Med Mycol 2012;50:225-33.
12. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010;50:1091-100.
13. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-70. (Pubitemid 47580314)
14. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010;50:1101-11.
15. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011;117:3921-8.
16. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
17. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-93. (Pubitemid 28482127)
18. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7. (Pubitemid 34289682)
19. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
20. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
21. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007;40:381-7. (Pubitemid 47202424)
22. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
23. Olesen R, Wejse C, Velez DR, et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 2007;8:456-67. (Pubitemid 47370843)
24. Chiarini M, Sabelli C, Melotti P, et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010;11:665-70.
25. May L, Kuningas M, van Bodegom D, et al. Genetic variation in pentraxin (PTX) 3 gene associates with PTX3 production and fertility in women. Biol Reprod 2010; 82:299-304.
26. Diamond JM, Meyer NJ, Feng R, et al. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2012;186:546-52.
27. Bozza S, Bistoni F, Gaziano R, et al. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 2006;108:3387-96.
28. Deban L, Russo RC, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010;11:328-34.
29. Han B, Mura M, Andrade CF, et al. TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol 2005;175:8303-11. (Pubitemid 41798396)
30. Inforzato A, Rivieccio V, Morreale AP, et al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J Biol Chem 2008;283:10147-61.